Amrix Capsule, Extended Release
Product Images NDC 63459-701

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amrix (NDC 63459-701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cephalon, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Cyclobenzaprine Hydrochloride, the active ingredient in AMRIX extended-release capsules. The diagram shows the molecular framework with three connected benzene rings and the associated side chain with the hydrochloride salt representation.*

FDA Label Image

Image 2

An illustration depicting a spoon holding a scoop of a creamy, textured substance, suggesting a dosing or administration method involving a spoon.*

FDA Label Image

Image 3

An instructional illustration showing how to hold and open a blister pack capsule by twisting the capsule at the area marked 'TOP' with finger and thumb.*

FDA Label Image

Image 4

An instructional illustration showing how to twist off or open the top of a cap or container. The image features two hands, with arrows indicating rotational movement in opposite directions around a cap labeled "TOP." This suggests the cap is designed to be twisted open.*

FDA Label Image

Image 5

An instructional illustration showing a hand opening a capsule and pouring the contents, depicted as small beads or pellets, onto a spoon. The image is likely related to administration guidance for the AMRIX extended-release capsule.*

FDA Label Image

Image 6

Illustration showing a woman holding a spoon with pill capsules on it, appearing ready to take the capsules orally. No additional product packaging or labeling is visible.*

FDA Label Image

Image 7

An illustration showing a person drinking a glass of water, likely demonstrating the proper way to take an oral medication such as the AMRIX extended-release capsule.*

FDA Label Image

Image 8

Label for AMRIX 15 mg extended-release capsules containing cyclobenzaprine hydrochloride. The label states the dosage form as capsules for oral use, with 60 capsules per bottle. It includes directions for adult dosage, warnings to keep out of reach of children, and storage instructions. The labeler is Cephalon, LLC, and the product is Rx only.*

FDA Label Image

Image 9

Label for AMRIX 30 mg extended-release capsules containing cyclobenzaprine hydrochloride, distributed by Teva Pharmaceuticals USA, Inc. The label includes dosage instructions for adults and safety warnings, with a lot/expiration coding area and barcodes. The labeler is Cephalon, LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.